[ad_1]
->
[사진=아이클릭아트]
The Seoul National University Hospital has become a leader in the treatment of cancer patients using genomic information.
Seoul National University Hospital announced on January 20 that it was operating "Syapse & # 39;
Earlier this year, the Seoul National University Hospital presented the first in Korea with the goal of leading to precision medical care.
Currently, the hospital information system does not have the ability to manage clinical and genomic data together.
The Seoul National University Hospital said: "At the moment, doctors have exchanged information on genomic information in order to use it for medical treatment," he said. he says "Medical and genomic data are managed separately"
SaizApps offers the best tailor-made treatment option for patients based on the data accumulated on the platform.
The safety of patient information is maintained even when they share clinical genomic data with a large number of medical personnel.
In the United States, more than 300 hospitals in 25 provinces use the SaaSpl platform.
Medical staff at Seoul National University Hospital expect that the sharing of gene therapy information through SaSaF will reduce unnecessary treatments and trial and error.
"Genomic data is vast, but the genetic mutation is different for each type of cancer," said the professor of hematology and oncology. "There has been a lack of interpretation of what the drugs cure and what progress will be made in the meantime"
In the future, Sai Apps will be released as an open platform. The Seoul National University Hospital plans to make it a platform to cover rare and chronic diseases.
On the other hand, the Seoul National University Hospital has applied next generation genome screening (NGS). I expect it to be higher. Currently, the rate of self-examination is 50%. The Ministry of Health and Wellness has selected gastric cancer, lung cancer, colorectal cancer, bad cancer, melanoma and pediatric neuroblastoma as target diseases.
Source link
